Table 1.
The demographic and clinical characteristics of breast cancer patients
| Parameter | No. of patients (%) |
|---|---|
| Age (years) | |
| <60 | 32 (57) |
| ≥60 | 24 (43) |
| T-stage | |
| cT1 | 16 (29) |
| cT2 | 35 (62) |
| cT3-4 | 5 (9) |
| N-stage | |
| N0 | 39 (70) |
| Nx | 17 (30) |
| M-stage | |
| M0 | 56 (100) |
| M1 | 0 (0) |
| TNM phase | |
| I | 11 (20) |
| II | 30 (53) |
| III | 15 (27) |
| Classification | |
| Luminal A | 36 (64) |
| HER2+ | 5 (9) |
| TNBC | 15 (27) |
| ER status | |
| negative | 20 (36) |
| positive | 36 (64) |
| PR status | |
| negative | 23 (41) |
| positive | 33 (59) |
| HER2 status | |
| negative | 51 (91) |
| positive | 5 (9) |
Abbreviations: TNM = tumor, node, metastases; ER = estrogen receptor; HER = human epidermal growth factor receptor; PR = progesterone receptor.